|
End-of-day quote
NYSE
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 12.09B 10.47B 9.9B 8.96B 16.83B 1,160B 16.95B 118B 45.46B 588B 45.41B 44.4B 1,875B | P/E 2026 * |
-82.9x | P/E 2027 * | 83.1x |
|---|---|---|---|---|---|
| Enterprise Value | 11.56B 10.02B 9.47B 8.58B 16.1B 1,109B 16.22B 113B 43.49B 563B 43.44B 42.48B 1,794B | EV / Sales 2026 * |
7.58x | EV / Sales 2027 * | 5.2x |
| Free-Float |
94.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 12.48B | |
| -1.38% | +0.20% | +46.42% | +96.33% | 70.24B | |
| -1.04% | -0.81% | +34.61% | +75.16% | 62.63B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 27.36B | |
| +1.79% | +2.68% | +29.39% | +15.02% | 25.71B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.83B | |
| +1.61% | -0.69% | +20.85% | -19.42% | 19.52B | |
| +1.26% | -14.23% | +170.04% | +298.75% | 15.51B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 14.69B | |
| -0.61% | -4.91% | -10.49% | +451.08% | 14.66B | |
| Average | -1.08% | -2.20% | +29.47% | +231.51% | 30.57B | |
| Weighted average by Cap. | -1.15% | -1.32% | +30.82% | +160.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.53B 1.32B 1.25B 1.13B 2.12B 146B 2.14B 14.92B 5.74B 74.24B 5.73B 5.61B 237B | 2.14B 1.86B 1.76B 1.59B 2.99B 206B 3.01B 20.97B 8.07B 104B 8.06B 7.88B 333B |
| Net income | -184M -159M -151M -136M -256M -17.64B -258M -1.8B -691M -8.94B -691M -675M -28.52B | 200M 173M 164M 148M 278M 19.18B 280M 1.95B 752M 9.73B 751M 735M 31.02B |
| Net Debt | -525M -454M -430M -389M -730M -50.31B -735M -5.13B -1.97B -25.51B -1.97B -1.93B -81.36B | -943M -817M -773M -699M -1.31B -90.48B -1.32B -9.22B -3.55B -45.88B -3.54B -3.46B -146B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
